Budget Panel To CBO: Are You Updating Analysis Of IRA’s Impact As New Data Emerge?

By Gabrielle Wanneh / November 21, 2023 at 3:56 PM
The House Budget Committee wants to know whether the Congressional Budget Office (CBO) is continually updating its analysis of how the Inflation Reduction Act’s drug price controls will affect pharmaceutical innovation, noting new data have emerged since CBO initially estimated the law will lead to 13 fewer drugs coming to market over the next 30 years. Committee Chair Jodey Arrington (R-TX), the committee’s Health Care Task Force Chair Michael Burgess (R-TX) and other members of the GOP-led health task force...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.